Avenue Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
05 Nov 24 | Sell€125 | Jay Kranzler | Individual | 61 | €2.05 | |
30 Sep 24 | Buy€1,120 | Jay Kranzler | Individual | 500 | €2.24 | |
11 Dec 23 | Sell€80,570 | Robert Davidow | Individual | 8,226.65 | €10.47 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 90 | 0.0153% |
Institutions | 16,394 | 2.78% |
Individual Insiders | 22,417 | 3.8% |
Public Companies | 47,298 | 8.01% |
General Public | 503,941 | 85.4% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 458.8%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
47,298 | €274.1k | 244% | no data | |||
17,464 | €101.2k | 0% | no data | |||
8,814 | €51.1k | 0% | 0.45% | |||
4,671 | €27.1k | -1.12% | no data | |||
3,347 | €19.4k | 0% | 0.02% | |||
1,181 | €6.8k | 0% | no data | |||
695 | €4.0k | -0.71% | no data | |||
617 | €3.6k | 0% | no data | |||
407 | €2.4k | 0% | no data | |||
381 | €2.2k | 0% | no data | |||
366 | €2.1k | 90.6% | no data | |||
337 | €2.0k | 0% | no data | |||
145 | €840.4 | 0% | no data | |||
119 | €689.5 | 58.7% | no data | |||
119 | €689.5 | 58.7% | no data | |||
90 | €521.6 | -1.1% | no data | |||
60 | €347.8 | 0% | no data | |||
44 | €255.2 | 0% | no data | |||
16 | €92.7 | -33.3% | no data | |||
14 | €81.1 | 0% | no data | |||
7 | €40.7 | 0% | no data | |||
6 | €34.9 | 500% | no data | |||
1 | €5.8 | 0% | no data |